-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nrer/RPHQGt/gl6cMU74rIiiRd12WzfphtX28dIelEM0AUx7Z/Bm3a1svGu/mKtW 1btVA30+rVABYd+33jvEVw== 0001144204-08-047332.txt : 20080814 0001144204-08-047332.hdr.sgml : 20080814 20080814161657 ACCESSION NUMBER: 0001144204-08-047332 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080630 FILED AS OF DATE: 20080814 DATE AS OF CHANGE: 20080814 EFFECTIVENESS DATE: 20080814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BAKER BROS ADVISORS LLC CENTRAL INDEX KEY: 0001263508 IRS NUMBER: 134093645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10519 FILM NUMBER: 081019278 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212418 13F-HR 1 v123066_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: June 30, 2008 Check here if Amendment [ ]; Amendment Number: _____ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Baker Bros. Advisors, LLC -------------------------------------------- Address: 667 Madison Avenue, 17th Floor -------------------------------------------- New York, NY 10065-8029 -------------------------------------------- Form 13F File Number: 28-10519 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Leo Kirby -------------------------------------------- Title: Chief Financial Officer -------------------------------------------- Phone: 212-339-5633 -------------------------------------------- Signature, Place, and Date of Signing: /s/ Leo Kirby New York, N.Y. August 12, 2008 - -------------------------- --------------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 93 ----------- Form 13F Information Table Entry Value: 1,263,200 ----------- (thousands) List of Other Included Managers: None Baker Brothers Form 13F 6-30-2008
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY Name of Issuer CUSIP (x1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - ---------------------------- ------- ------- ------- --- ---- ---------- -------- ---- ------ ---- Acadia Pharmaceuticals Inc. COM 004225108 10,328 2,798,951 SH SOLE 2,798,951 Acorda Therapeutics COM 00484M106 43,430 1,322,862 SH SOLE 1,322,862 Adolor Corp. COM 00724X102 1,395 254,515 SH SOLE 254,515 Alkermes COM 01642T108 2,216 179,327 SH SOLE 179,327 Allos Therapeutics Inc. COM 019777101 77,728 11,248,621 SH SOLE 11,248,621 Alsius Corp. COM 021211107 78 64,850 SH SOLE 64,850 Altus Pharmaceuticals Inc. COM 02216N105 180 40,477 SH SOLE 40,477 Amicus Therapeutics COM 03152W109 14,849 1,390,368 SH SOLE 1,390,368 Anadys Pharmaceuticals Inc. COM 03252Q408 1,019 452,835 SH SOLE 452,835 Anesiva Inc. COM 21872P501 4,077 1,381,977 SH SOLE 1,381,977 AP Pharma COM 00202J203 1,724 1,512,446 SH SOLE 1,512,446 Aradigm Corp. COM 038505301 75 100,000 SH SOLE 100,000 Ardea Biosciences Inc. COM 03969P107 46,842 3,653,765 SH SOLE 3,653,765 Arena Pharmaceuticals Inc. COM 040047102 141 27,246 SH SOLE 27,246 Array Biopharma Inc. COM 04269X105 1,007 214,219 SH SOLE 214,219 Atherogenics Inc. COM 047439104 14 24,471 SH SOLE 24,471 Autoimmune Inc. COM 052776101 47 26,100 SH SOLE 26,100 Auxilium COM 05334D107 109,250 3,249,563 SH SOLE 3,249,563 Biocryst Pharmaceuticals Inc. COM 09058V103 16,572 5,918,411 SH SOLE 5,918,411 Biomarin Pharmaceutical Inc. COM 09061G101 2,058 71,021 SH SOLE 71,021 Cadence Pharmaceuticals COM 12738T100 1,010 165,784 SH SOLE 165,784 Celgene COM 151020104 72,019 1,127,593 SH SOLE 1,127,593 Chelsea Therapeutics COM 163428105 5,545 1,136,263 SH SOLE 1,136,263 Critical Therapeutics Inc. COM 22674T105 416 1,124,474 SH SOLE 1,124,474 Cubist COM 229678AC1 4,134 231,472 SH SOLE 231,472 Curagen COM 23126R101 150 156,013 SH SOLE 156,013 Cyclacel Pharmaceuticals COM 23254L108 365 191,186 SH SOLE 191,186 Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% PFD CONV EX 23254L207 292 95,500 SH SOLE 95,500 Cytokinetics Inc. COM 23282W100 6,335 1,707,673 SH SOLE 1,707,673 Decode Genetics COM 2435686104 236 252,076 SH SOLE 252,076 Dendreon COM 24823Q107 598 134,423 SH SOLE 134,423 Depomed COM 249908104 1,724 537,217 SH SOLE 537,217 Genelabs Technologies Inc. COM 368706206 98 154,937 SH SOLE 154,937 Genomic Health Inc. COM 37244C101 99,587 5,200,387 SH SOLE 5,200,387 Halozyme Therapeutics Inc. COM 40637H109 17,780 3,304,796 SH SOLE 3,304,796 Icagen Inc. COM 45104P104 93 59,473 SH SOLE 59,473 Idera Pharmaceuticals Inc. COM 45168K108 13,698 937,584 SH SOLE 937,584 Immunogen Inc. COM 45253H101 1,538 502,734 SH SOLE 502,734 Immunomedics, Inc. COM 452907108 160 75,244 SH SOLE 75,244 Incyte Corp. COM 45337C102 68,623 9,017,432 SH SOLE 9,017,432 Indevus Pharmaceuticals COM 454072109 2,469 1,572,883 SH SOLE 1,572,883 Infinity Pharmaceuticals Inc. COM 45665G303 671 85,632 SH SOLE 85,632 Inhibitex Inc. COM 45719T103 103 155,964 SH SOLE 155,964 Inspire COM 457733103 2,222 519,241 SH SOLE 519,241 Intermune Inc. COM 45884X103 18,729 1,427,494 SH SOLE 1,427,494 Isis Pharmaceuticals Inc. COM 464330109 257 18,859 SH SOLE 18,859 Ligand Pharmaceuticals Inc. CL B 53220K207 32 12,321 SH SOLE 12,321 Medarex COM 583916101 2,068 312,834 SH SOLE 312,834 Metabasis Therapeutics Inc. COM 59101M105 3,551 2,290,668 SH SOLE 2,290,668 Micromet COM 59509C105 7,127 2,689,114 SH SOLE 2,689,114 Myriad Genetics Inc. COM 62855J104 15,911 349,528 SH SOLE 349,528 Neose Technologies Inc. COM 640522108 675 2,251,191 SH SOLE 2,251,191 Neurocrine Biosciences COM 64125C109 210 50,000 SH SOLE 50,000 Neurogen Corp. COM 64124E106 5,301 5,147,078 SH SOLE 5,147,078 Novo-Nordisk COM 670100205 27,965 423,717 SH SOLE 423,717 Onyx Inc. COM 683399109 5,360 150,574 SH SOLE 150,574 Optimer Pharmaceuticals COM 68401H104 9,326 1,149,981 SH SOLE 1,149,981 OSI Pharmaceuticals COM 671040103 2,741 66,344 SH SOLE 66,344 PDL Biopharma COM 69329Y104 116 10,891 SH SOLE 10,891 Pharmasset Inc. COM 71715N106 996 52,747 SH SOLE 52,747 Pozen Inc. COM 73941U102 19,526 1,794,694 SH SOLE 1,794,694 Progenics Pharmaceuticals COM 743187106 15,256 961,306 SH SOLE 961,306 Regeneron COM 78556F107 3,065 212,260 SH SOLE 212,260 Rigel Pharmaceuticals COM 766559603 1,259 55,560 SH SOLE 55,560 Salix Pharmaceuticals, Inc. COM 795435106 11,159 1,587,349 SH SOLE 1,587,349 Seattle Genetics Inc. COM 812578102 109,237 12,912,124 SH SOLE 12,912,124 Sequenom Inc. COM 817337405 398 24,953 SH SOLE 24,953 Siga Technologies Inc. COM 826917106 2,910 932,837 SH SOLE 932,837 Spectrum Pharmaceuticals Inc. COM 84763A108 586 421,349 SH SOLE 421,349 Sunesis Pharmaceuticals Inc. COM 867328502 1,853 1,286,466 SH SOLE 1,286,466 Supergen COM 868059106 2,281 1,112,917 SH SOLE 1,112,917 Symyx Technologies, Inc. COM 87155S108 2,272 325,442 SH SOLE 325,442 Tapestry Pharmaceuticals Inc. COM 876031204 33 1,939,453 SH SOLE 1,939,453 Targacept COM 87611R306 3,178 437,181 SH SOLE 437,181 Threshold Pharma COM 885807107 838 2,263,600 SH SOLE 2,263,600 Torreypines Therapeutics COM 89235K105 254 204,452 SH SOLE 204,452 Trimeris Inc. COM 896263100 16,336 3,461,175 SH SOLE 3,461,175 Vanda Pharmaceuticals Inc. COM 921659108 513 155,942 SH SOLE 155,942 Vertex Pharmaceuticals Inc. COM 92532F100 2,218 66,262 SH SOLE 66,262 Via Pharmaceuticals COM 92554T103 231 102,881 SH SOLE 102,881 Vion Pharm COM 927624AA4 51 43,101 SH SOLE 43,101 Viropharma Inc. COM 928241108 83,461 7,546,147 SH SOLE 7,546,147 Xenoport Inc. COM 98411C100 33,544 859,448 SH SOLE 859,448 Zymogenetics COM 98411C100 1,591 188,951 SH SOLE 188,951 Amylin Pharmaceuticals Notes 2.5% 4/15/11 CONV BONDS 032346AD0 24,140 23,465,000 PRN SOLE 23,465,000 Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 CONV BONDS 09061GAD3 18,885 12,000,000 PRN SOLE 12,000,000 Biomarin Pharmaceuticals Notes 2.5% 3/29/2013 CONV BONDS 09061GAC5 34,626 18,224,000 PRN SOLE 18,224,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAE2 17,644 18,972,000 PRN SOLE 18,972,000 Incyte Genomics Notes 3.5% 2/15/2011 CONV BONDS 45337CAF9 18,368 19,750,000 PRN SOLE 19,750,000 Intermune Inc Notes .25% 3/01/2011 CONV BONDS 45884XAC7 13,894 15,000,000 PRN SOLE 15,000,000 Medarex Inc Notes 2.25% 5/15/2011 CONV BONDS 583916AG6 11,776 13,158,000 PRN SOLE 13,158,000 Vertex Pharmaceuticals Notes 4.75% 2/15/13 CONV BONDS 92532FAM2 40,868 25,948,000 PRN SOLE 25,948,000 Viropharma Inc. Notes 2.0% 3/15/2017 CONV BONDS 928241AH1 37,688 45,000,000 PRN SOLE 45,000,000
-----END PRIVACY-ENHANCED MESSAGE-----